Back
CytoMed Therapeutics Stock Predictions
Sponsored
GDTC
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62
GDTC
CytoMed Therapeutics
Last Price:
2.20
Seasonality Move:
-35.48%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.CytoMed Therapeutics Stock Forecast
-
Is CytoMed Therapeutics Stock Undervalued?
The current CytoMed Therapeutics [GDTC] share price is $2.26. The Score for GDTC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal. - GDTC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will CytoMed Therapeutics Stock Go Up Next Year?
Data Unavailable
CytoMed Therapeutics Stock Rating
Data Unavailable
CytoMed Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Singapore
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
w2.cytomed.sg
52-Week Data
52-Week High:
5.50
52-Week Low:
1.20
Prediction Charts
Market Cap:
26.07M
Price in USD:
2.26
Volume:
2.69K
Beta:
-0.09
Technical Analysis
SMA50:
2.07
SMA100:
1.92
SMA200:
2.03
52-Wk Change:
-38.93%
Stock Predictions
-
Is CytoMed Therapeutics stock public?
Yes, CytoMed Therapeutics is a publicly traded company. -
What is the CytoMed Therapeutics stock quote today?
The CytoMed Therapeutics stock price is 2.26 USD today. -
How to buy CytoMed Therapeutics stock online?
You can buy CytoMed Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-5 | 2.61 | 2.62 | 2.83 | 2.41 |
Nov-6 | 2.44 | 2.44 | 2.49 | 2.36 |
Nov-7 | 2.29 | 2.54 | 2.59 | 2.24 |
Nov-8 | 2.15 | 2.31 | 2.55 | 2.14 |
Nov-11 | 2.11 | 2.39 | 2.69 | 2.11 |
Nov-12 | 2.31 | 2.27 | 2.31 | 2.18 |
Nov-13 | 2.40 | 2.22 | 2.60 | 2.15 |
Nov-14 | 2.37 | 2.12 | 2.40 | 2.12 |
Nov-15 | 2.20 | 2.17 | 2.52 | 1.83 |
Nov-18 | 2.10 | 1.94 | 2.30 | 1.85 |
Nov-19 | 1.95 | 2.01 | 2.27 | 1.95 |
Nov-20 | 2.15 | 2.21 | 2.35 | 1.88 |
Nov-21 | 2.25 | 2.20 | 2.27 | 2.19 |
Nov-22 | 2.05 | 2.26 | 2.35 | 2.05 |
CytoMed Therapeutics Earnings
Data Unavailable
CytoMed Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.
* CytoMed Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.